Prescription drug · NDA
Catapres-TTS-3 (clonidine transdermal system) NDC 82089-103
Clonidine .3 mg/d · Patch · Transdermal · Technomed Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82089-103-34 | 82089010334 | 4 POUCH in 1 CARTON (82089-103-34) / 1 PATCH in 1 POUCH / 1 d in 1 PATCHMarketed from Mar 1, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Catapres-TTS-3
- Generic name (nonproprietary)
- clonidine transdermal system
- Active ingredients
- Clonidine — .3 mg/d
- Dosage form
- Patch
- Route
- Transdermal
- Labeler
- Technomed Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018891
- Marketing start
- Marketing end
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 82089-103_e826dfa2-e206-4274-8354-c47f17a04f5dSPL ID e826dfa2-e206-4274-8354-c47f17a04f5dSPL set ID d4a55825-7041-42f4-b3b2-dd7a25dbe793RxCUI 998671, 998673, 998675, 998677, 998679, 998681UNII MN3L5RMN02
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482089010334followed by a unit qualifier and the quantityPackage 82089-0103-34. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Catapres‑TTS ® is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 018891
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clonidine Transdermal System USP, 0.2 mg/dayclonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | TruPharma, LLC | 52817-506 |
| Clonidine Transdermal System USP, 0.1 mg/dayclonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | TruPharma, LLC | 52817-505 |
| Clonidine Transdermal System USP, 0.3 mg/dayclonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | TruPharma, LLC | 52817-507 |
| Clonidine Transdermal System USP, 0.1 mg/dayclonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | TruPharma, LLC | 52817-610 |
| Clonidine Transdermal System USP, 0.2 mg/dayclonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | TruPharma, LLC | 52817-611 |
| Clonidine Transdermal System USP, 0.3 mg/dayclonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | TruPharma, LLC | 52817-612 |
| Catapres-TTS-2clonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | Technomed Inc. | 82089-102 |
| Catapres-TTS-1clonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | Technomed Inc. | 82089-101 |
| Catapres-TTS-3clonidine transdermal system | Clonidine .3 mg/d | PatchTransdermal | Technomed Inc. | 82089-203 |
| Catapres-TTS-1clonidine transdermal system | Clonidine .1 mg/d | PatchTransdermal | Technomed Inc. | 82089-201 |
| Catapres-TTS-2clonidine transdermal system | Clonidine .2 mg/d | PatchTransdermal | Technomed Inc. | 82089-202 |